NO832437L - Fremgangsmaate for fremstilling av n-imidazolyl derivater av bicykliske forbindelser - Google Patents

Fremgangsmaate for fremstilling av n-imidazolyl derivater av bicykliske forbindelser

Info

Publication number
NO832437L
NO832437L NO832437A NO832437A NO832437L NO 832437 L NO832437 L NO 832437L NO 832437 A NO832437 A NO 832437A NO 832437 A NO832437 A NO 832437A NO 832437 L NO832437 L NO 832437L
Authority
NO
Norway
Prior art keywords
procedure
preparation
bicyclic compounds
imidazolyl derivatives
imidazolyl
Prior art date
Application number
NO832437A
Other languages
English (en)
Other versions
NO161439C (no
NO161439B (no
Inventor
Paolo Cozzi
Germano Carganico
Antonio Pillan
Umberto Branzoli
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NO832437L publication Critical patent/NO832437L/no
Publication of NO161439B publication Critical patent/NO161439B/no
Publication of NO161439C publication Critical patent/NO161439C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO832437A 1982-07-05 1983-07-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive n-imidazolylderivater av bicykliske forbindelser. NO161439C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8219412 1982-07-05

Publications (3)

Publication Number Publication Date
NO832437L true NO832437L (no) 1984-01-06
NO161439B NO161439B (no) 1989-05-08
NO161439C NO161439C (no) 1989-08-16

Family

ID=10531484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832437A NO161439C (no) 1982-07-05 1983-07-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive n-imidazolylderivater av bicykliske forbindelser.

Country Status (33)

Country Link
US (2) US4510149A (no)
JP (1) JPS5927874A (no)
KR (1) KR910000414B1 (no)
AT (1) AT386201B (no)
AU (1) AU557304B2 (no)
BE (1) BE897207A (no)
CA (1) CA1202030A (no)
CH (1) CH655102A5 (no)
CS (1) CS273310B2 (no)
CZ (1) CZ413491A3 (no)
DE (1) DE3324069C2 (no)
DK (1) DK163359C (no)
ES (1) ES523609A0 (no)
FI (1) FI74466C (no)
FR (1) FR2529547B1 (no)
GR (1) GR77577B (no)
HK (1) HK101187A (no)
HU (1) HU193529B (no)
IE (1) IE55894B1 (no)
IL (1) IL69152A0 (no)
IT (1) IT1163641B (no)
LU (1) LU84895A1 (no)
MY (1) MY104376A (no)
NL (1) NL8302347A (no)
NO (1) NO161439C (no)
NZ (1) NZ204802A (no)
PH (1) PH21115A (no)
PT (1) PT76979B (no)
SE (1) SE461791B (no)
SG (1) SG73487G (no)
SU (1) SU1342414A3 (no)
YU (1) YU43545B (no)
ZA (1) ZA834865B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
JPH062745B2 (ja) * 1984-07-16 1994-01-12 第一製薬株式会社 インダン誘導体
US4659730A (en) * 1984-06-18 1987-04-21 Eli Lilly And Company Aromatase inhibiting imidazole derivatives
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB8612796D0 (en) * 1986-05-27 1986-07-02 Fbc Ltd Fungicides
PH24144A (en) * 1987-06-03 1990-03-22 Erba Carlo Spa A method of treating nephropathies using n-imidazolyl derivatives of bicyclic compounds
US4992465A (en) * 1988-09-27 1991-02-12 Ciba-Geigy Corporation 3-amino-dihydro-(1)-benzopyrans
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
GB9025848D0 (en) * 1990-11-28 1991-01-09 Erba Carlo Spa Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
US5559248A (en) * 1995-04-05 1996-09-24 Bristol-Myers Squibb Co. Retinoid-like heterocycles
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
GC0000177A (en) * 1998-12-17 2006-03-29 Smithkline Beecham Thrombopoietin mimetics
CY2010012I2 (el) * 2000-05-25 2020-05-29 Novartis Ag Μιμητικα θρομβοποιητινης
US20110212054A1 (en) * 2000-05-25 2011-09-01 Glaxosmithkline Llc. Thrombopoietin mimetics
DE10054639B4 (de) * 2000-11-03 2004-05-06 Jenapharm Gmbh & Co. Kg Verwendung von RanBPM als Co-Modulator von Steroidhormonrezeptoren
JP2004527541A (ja) 2001-03-01 2004-09-09 スミスクライン・ビーチャム・コーポレイション トロンボポエチン模倣物
MY142390A (en) * 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
DE602004001459T2 (de) * 2003-04-16 2007-02-01 Huntsman Advanced Materials (Switzerland) Gmbh 1-imidazolylmethyl-substituierte 2-naphtole und ihre verwendung als beschleuniger für tieftemperaturhärtung
TW200526638A (en) * 2003-10-22 2005-08-16 Smithkline Beecham Corp 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
US9271963B2 (en) * 2005-03-03 2016-03-01 Universitat Des Saarlandes Selective inhibitors of human corticosteroid synthases
CN101578272A (zh) * 2006-12-18 2009-11-11 诺瓦提斯公司 1-取代的咪唑衍生物和它们作为醛固酮合酶抑制剂的用途
ECSP077628A (es) 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
JP2012528184A (ja) 2009-05-29 2012-11-12 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー トロンボポエチンアゴニスト化合物の投与の方法
WO2016022448A1 (en) * 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2443671A (en) * 1942-12-03 1948-06-22 Westinghouse Electric Corp Arc welding system
US3485917A (en) * 1966-04-14 1969-12-23 Janssen Pharmaceutica Nv Composition and method for combating fungus with imidazole carboxylates
US3541109A (en) * 1968-06-25 1970-11-17 Du Pont 1-substituted imidazoles useful in acth reserve assay
US3637731A (en) * 1968-07-18 1972-01-25 Du Pont 1-(alkylsubstituted phenyl)imidazoles useful in acth reserve assay
IE40911B1 (en) * 1974-04-11 1979-09-12 Schering Ag Imidazole derivatives and process for their manufacture
DE2418502C3 (de) * 1974-04-11 1980-04-24 Schering Ag, 1000 Berlin Und 4619 Bergkamen Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4284641A (en) * 1977-08-26 1981-08-18 Burroughs Wellcome Co. Pharmaceutically active imidazole derivatives
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
JPS5681566A (en) * 1979-12-05 1981-07-03 Yoshitomi Pharmaceut Ind Ltd Imidazole derivative
EP0098456B1 (en) * 1980-02-14 1989-05-24 Sandoz Ag Peptides comprising a (1s,2r,3r)- or (1r,2s,3s)-1-nitrilo-1-carbonyl-3-methyl-2-oxy-heptane or -hept-5-ene residue useful in the total synthesis of cyclosporins, and processes for their production
IL62122A0 (en) * 1980-03-04 1981-03-31 Erba Farmitalia N-imidazolyl derivatives of 1-chroman,their preparation and pharmaceutical compositions containing them
GB2071655B (en) * 1980-03-04 1983-06-22 Erba Farmitalia N-amidazolyl derivatives of1-chroman and process for their preparation
ZA81980B (en) * 1980-03-04 1982-02-24 Erba Farmitalia N-imidazolyl derivatives of 1-chroman and process for their preparation
ZA825142B (en) * 1981-07-23 1983-04-27 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,j-tetrahydro-naphthalene, indan and 2-substituted-1-chroman, and process for their preparation
IL66242A0 (en) * 1981-07-23 1982-11-30 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
JPS6081566A (ja) * 1983-10-07 1985-05-09 Nissan Motor Co Ltd ロツクアツプトルクコンバ−タのスリツプ制御装置

Also Published As

Publication number Publication date
YU144283A (en) 1986-10-31
SG73487G (en) 1988-03-04
CZ413491A3 (en) 1993-10-13
AU1654083A (en) 1984-01-12
SE8303824L (sv) 1984-01-06
KR910000414B1 (ko) 1991-01-25
NO161439C (no) 1989-08-16
ES8503669A1 (es) 1985-03-01
US4602022A (en) 1986-07-22
FR2529547B1 (fr) 1986-09-05
NO161439B (no) 1989-05-08
CA1202030A (en) 1986-03-18
IT1163641B (it) 1987-04-08
IT8321886A0 (it) 1983-07-01
JPS5927874A (ja) 1984-02-14
AT386201B (de) 1988-07-25
MY104376A (en) 1994-03-31
AU557304B2 (en) 1986-12-18
ES523609A0 (es) 1985-03-01
FI832420L (fi) 1984-01-06
IL69152A0 (en) 1983-11-30
FI74466B (fi) 1987-10-30
DE3324069C2 (de) 1994-08-25
CH655102A5 (de) 1986-03-27
KR840005433A (ko) 1984-11-12
SU1342414A3 (ru) 1987-09-30
YU43545B (en) 1989-08-31
DK163359B (da) 1992-02-24
HK101187A (en) 1988-01-08
NZ204802A (en) 1986-04-11
ZA834865B (en) 1984-03-28
DK163359C (da) 1992-07-13
PT76979A (en) 1983-08-01
DK307983A (da) 1984-01-06
CS509483A2 (en) 1990-08-14
ATA247383A (de) 1987-12-15
SE461791B (sv) 1990-03-26
DK307983D0 (da) 1983-07-04
US4510149A (en) 1985-04-09
DE3324069A1 (de) 1984-01-26
HU193529B (en) 1987-10-28
IE55894B1 (en) 1991-02-14
SE8303824D0 (sv) 1983-07-04
IE831564L (en) 1984-01-05
FR2529547A1 (fr) 1984-01-06
FI74466C (fi) 1988-02-08
FI832420A0 (fi) 1983-07-01
JPH0454662B2 (no) 1992-08-31
CS273310B2 (en) 1991-03-12
GR77577B (no) 1984-09-24
PH21115A (en) 1987-07-16
BE897207A (fr) 1984-01-04
NL8302347A (nl) 1984-02-01
PT76979B (en) 1986-01-09
LU84895A1 (fr) 1983-11-23

Similar Documents

Publication Publication Date Title
NO832437L (no) Fremgangsmaate for fremstilling av n-imidazolyl derivater av bicykliske forbindelser
NO841158L (no) Fremgangsmaate for fremstilling av 2-azetidin-4-substituerte forbindelser
NO811731L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater
NO813678L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO843956L (no) Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner
NO168154C (no) Fremgangsmaate for fremstilling av unilamellaere liposomer
NO851524L (no) Fremgangsmaate for fremstilling av fenetanolamin-forbindelser
NO814065L (no) Fremgansmaate for fremstilling av imidazolylfenylamidiner
NO844631L (no) Fremgangsmaate for fremstilling av tremasse
NO845207L (no) Fremgangsmaate for fremstilling av diaminopolyalkenyletere
NO823637L (no) Fremgangsmaate for fremstilling av eburnamoninderivater
NO833531L (no) Fremgangsmaate for fremstilling av 7-substituerte-3-vinyl-3-cefem-forbindelser
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
ES524978A0 (es) Procedimiento de preparacion de derivados de la quinuclidina
NO830176L (no) Fremgangsmaate for fremstilling av ultrarent toriumfluorid
NO813814L (no) Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser
NO813477L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO833664L (no) Fremgangsmaate til fremstilling av 4-metyl-5-alkyl-tiometylimidazoler
NO830901L (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske benzenoid-forbinsdelser
NO831874L (no) Fremgangsmaate for fremstilling av trifenylbuten-derivater
NO831994L (no) Fremgangsmaate for fremstilling av pyrimidinon-derivater
NO834437L (no) Fremgangsmaate for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater
NO812842L (no) Fremgangsmaate for fremstilling av aminoacetonitil-derivater
NO844441L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske tiadiazinon-derivater
NO821686L (no) Fremgangsmaate for fremstilling av penicillinderivater